Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells

Beneficial Microbes

Volumn 6, Issue 3, 2015, Pages 325-336

  Citar M ^a,b   Hacin, B ^c   Tompa, G ^a   Stempelj M ^b   Rogelj, I ^a   Dolinsek J ^d   Narat, M ^a   Bogovic Matijasic B ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Pharmaceutical Company   (Slovenia)

^c Veterinary Faculty National Veterinary Institute   (Slovenia)

^d UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Bifidobacterium; Intestinal microbiota; Lactobacillus; Probiotic; Safety assessment

Indexed keywords

ACETIC ACID; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ENROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; KANAMYCIN; LACTIC ACID; METRONIDAZOLE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; IL10 PROTEIN, HUMAN; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; FERMENTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; UPREGULATION; ADOLESCENT; CHILD; DRUG EFFECTS; FEMALE; GASTROINTESTINAL DISEASE; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY;

ADOLESCENT; BIFIDOBACTERIUM; CHILD; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTESTINAL MUCOSA; LACTOBACILLUS; MALE; MONOCYTES; PROBIOTICS;

EID: 84928898049     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2014.0081     Document Type: Article

References (59)

1. Ahlroos, T. and Tynkkynen, S., 2009. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. Journal of Applied Microbiology 106: 506-514.
2. Ahrne, S., Nobaek, S., Jeppsson, B., Adlerberth, I., Wold, A.E. and Molin, G., 1998. The normal Lactobacillus flora of healthy human rectal and oral mucosa. Journal of Applied Microbiology 85: 88-94.
3. Aires, J., Doucet-Populaire, F. and Butel, M.J., 2007. Tetracycline resistance medicated by tet(W), tet(M), and tet(O) genes of Bifidobactefium isolates from humans. Applied and Environmental Microbiology 73: 2751-2754.
4. Andrighetto, C., Psomas, E., Tzanetakis, N., Suzzi, G. and Lombardi, A., 2000. Randomly amplified polymorphic DNA (RAPD) PCR for the identification of yeasts isolated from dairy products. Letters in Applied Microbiology 30: 5-9.
5. Araujo-Perez, F., McCoy, A.N., Okechukwu, C., Carroll, I.M., Smith, K.M., Jeremiah, K., Sandler, R.S., Asher, G.N. and Keku, T.O., 2012. Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 3: 530-535.
6. Ardizzone, S. and Porro, G.B., 2005. Biologic therapy for inflammatory bowel disease. Drugs 65: 2253-2286.
7. Bogovic-Matijasic, B. and Rogelj, I., 1998. Bacteriocin complex of Lactobacillus acidophilus LF221-production studies in MRS media at different pH values and effect against Lactobacillus helveticus ATCC 15009. Process Biochemistry 33: 345-352.
8. Danielsen, M. and Wind, A., 2003. Susceptibility of Lactobacillus spp. to antimicrobial agents. International Journal of Food Microbiology 82: 1-11.
9. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer, M.A., Swidsinski, A., Beaugerie, L. and Colombel, J.F., 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
10. Domann, E., Hong, G., Imirzalioglu, C., Turschner, S., Kuhle, J., Watzel, C., Hain, T., Hossain, H. and Chakraborty, T., 2003. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. Journal of Clinical Microbiology 41: 5500-5510.
11. Drouault-Holowacz, S., Foligne, B., Dennin, V., Goudercourt, D., Terpend, K., Burckel, A. and Pot, B., 2006. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations. Clinical Nutrition 25: 994-1003.
12. European Food Safety Authority (EFSA), 2012. Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)-guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal 10: 1-10.
13. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. and Ogarra, A., 1991. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147: 3815-3822.
14. Fitzpatrick, L.R., Small, J., Hoerr, R.A., Bostwick, E.F., Maines, L. and Koltun, W.A., 2008. In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis. British Journal of Nutrition 100: 530-541.
15. Gasche, C., Bakos, S., Dejaco, C., Tillinger, W., Zakeri, S. and Reinisch, W., 2000. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. Journal of Clinical Immunology 20: 362-370.
16. Gologan, S., Iacob, R., Iancu, D., Iacob, S., Cotruta, B., Vadan, R., Catuneanu, A.M., Constantinescu, I., Barbarii, L., Gheorghe, C. and Diculescu, M., 2013. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. Journal of Crohn's and Colitis 7: 622-630.
17. Hacin, B., Rogelj, I. and Matijasic, B.B., 2008. Lactobacillus isolates from weaned piglets' mucosa with inhibitory activity against common porcine pathogens. Folia Microbiologica 53: 569-576.
18. Hautefort, I., Roels, A., Tailliez, P., Ladire, M., Raibaud, P., Ducluzeau, R. and Fons, M., 1999. Selection of Lactobacillus fermentum strains able to durably colonize the digestive tract of mice harboring a complex human flora. FEMS Microbiology Ecology 29: 23-31.
19. Holdeman, L.V., Cato, E.P. and Moore, W.E.C., 1977. Anaerobe laboratory manual. Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
20. Klare, I., Konstabel, C., Werner, G., Huys, G., Vankerckhoven, V., Kahlmeter, G., Hildebrandt, B., Muller-Bertling, S., Witte, W. and Goossens, H., 2007. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. Journal of Antimicrobial Chemotherapy 59: 900-912.
21. Klein, G., Hallmann, C., Casas, I.A., Abad, J., Louwers, J. and Reuter, G., 2000. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. Journal of Applied Microbiology 89: 815-824.
22. Klijn, N., Weerkamp, A.H. and De Vos, W.M., 1991. Identification of mesophilic lactic acid bacteria by using polymerase chain reaction-amplified variable regions of 16S rRNA and specific DNA probes. Applied and Environmental Microbiology 57: 3390-3393.
23. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N. and Schuler, G., 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. Journal of Experimental Medicine 184: 1591-1591.
24. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
25. Lindsay, J.O., Sandison, A., Cohen, P., Brennan, F.M. and Hodgson, H.J.F., 2004. IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis. Digestive Diseases and Sciences 49: 1327-1334.
26. Matsumoto, S., Hara, T., Hori, T., Mitsuyama, K., Nagaoka, M., Tomiyasu, N., Suzuki, A. and Sata, M., 2005. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clinical and Experimental Immunology 140: 417-426.
27. McCartney, A.L., Wang, W.Z. and Tannock, G.W., 1996. Molecular analysis of the composition of the bifidobacterial and Lactobacillus microflora of humans. Applied and Environmental Microbiology 62: 4608-4613.
28. Meijerink, M., Van Hemert, S., Taverne, N., Wels, M., De Vos, P., Bron, P.A., Savelkoul, H.F., Van Bilsen, J., Kleerebezem, M. and Wells, J.M., 2010. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One 5: e10632.
29. Messaoudi, S., Madi, A., Prevost, H., Feuilloley, M., Manai, M., Dousset, X. and Connil, N., 2012. In vitro evaluation of the probiotic potential of Lactobacillus salivarius SMXD51. Anaerobe 18: 584-589.
30. Molin, G., Jeppsson, B., Johansson, M.L., Ahrne, S., Nobaek, S., Stahl, M. and Bengmark, S., 1993. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. Journal of Applied Bacteriology 74: 314-323.
31. Mudter, J. and Neurath, M.F., 2007a. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56: 293-303.
32. Mudter, J. and Neurath, M.F., 2007b. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflammatory Bowel Diseases 13: 1016-1023.
33. Nelson, R.R.S., 1999. Intrinsically vancomycin-resistant Gram-positive organisms: clinical relevance and implications for infection control. Journal of Hospital Infection 42: 275-282.
34. Nielsen, D.S., Moller, P.L., Rosenfeldt, V., Paerregaard, A., Michaelsen, K.F. and Jakobsen, M., 2003a. Case study of the distribution of mucosa-associated Bifidobacterium species, Lactobacillus species, and other lactic acid bacteria in the human colon. Applied and Environmental Microbiology 69: 7545-7548.
35. Nielsen, O.H., Kirman, I., Rudiger, N., Hendel, J. and Vainer, B., 2003b. Upregulation of interleukin-12 and-17 in active inflammatory bowel disease. Scandinavian Journal of Gastroenterology 38: 180-185.
36. O'Donnell, M.M., O'Toole, P.W. and Ross, R.P., 2013. Catabolic flexibility of mammalian-associated lactobacilli. Microbial Cell Factories 12.
37. O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F.Y., Chen, K.S., O'Sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F. and Quigley, E.M.M., 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.
38. Oser, B.L., 1965. Hawk's physiological chemistry. McGraw-Hill, New York, NY, USA.
39. Peluso, I., Pallone, F. and Monteleone, G., 2006. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic inplication. World Journal of Gastroenterology 12: 5606-5610.
40. Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Diaz-Ropero, M.P., Olivares, M., Xaus, J., Zarzuelo, A. and Galvez, J., 2005. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World Journal of Gastroenterology 11: 5185-5192.
41. Pfaffl, M.W., 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29.
42. Pulido, R.P., Ben Omar, N., Abriouel, H., Lopez, R.L., Canamero, M.M., Guyot, J.P. and Galvez, A., 2007. Characterization of lactobacilli isolated from caper berry fermentations. Journal of Applied Microbiology 102: 583-590.
43. Rennick, D.M. and Fort, M.M., 2000. Lessons from genetically engineered animal models-XII. IL-10-deficient (IL-10(-/-)) mice and intestinal inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology 278: G829-G833.
44. Rogelj, I., Bogovic Matijašic, B., Hacin, B., Citar, M., Štempelj, M. and Švigelj, K., 2013. Method for isolation and selection of bacterial strains, bacterial strains, and method for their use. Slovenian Intellectual Property Office Patent P 20300372.
45. Sanchez-Munoz, F., Dominguez-Lopez, A. and Yamamoto-Furusho, J.K., 2008. Role of cytokines in inflammatory bowel disease. World Journal of Gastroenterology 14: 4280-4288.
46. Schwiertz, A., Jacobi, M., Frick, J.S., Richter, M., Rusch, K. and Köhler, H., 2010. Microbiota in pediatric inflammatory bowel disease. Journal of Pediatrics 157: 240-244.
47. Selinger, C.P., Bell, A., Cairns, A., Lockett, M., Sebastian, S. and Haslam, N., 2013. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. Journal of Hospital Infection 84: 159-165.
48. Skraban, J., Dzeroski, S., Zenko, B., Mongus, D., Gangl, S. and Rupnik, M., 2013. Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes. PloS One 8: e58005.
49. Smokvina, T., Wels, M., Polka, J., Chervaux, C., Brisse, S., Boekhorst, J., Vlieg, J.E.T.V. and Siezen, R.J., 2013. Lactobacillus paracasei comparative genomics: towards species pan-genome definition and exploitation of diversity. PLoS One 8: e68731.
50. Sood, A., Midha, V., Makharia, G.K., Ahuja, V., Singal, D., Goswami, P. and Tandon, R.K., 2009. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology 7: 1202-1209.
51. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. and Remaut, E., 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355.
52. Tagore, A., Gonsalkorale, W.M., Pravica, V., Hajeer, A.H., McMahon, R., Whorwell, P.J., Sinnott, P.J. and Hutchinson, I.V., 1999. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54: 386-390.
53. Talafantova, M., Mandel, L. and Trebichavsky, I., 1987. The adherence of Escherichia coli to the intestinal epithelium of piglets. Nahrung 31: 477-479.
54. Torriani, S., Zapparoli, G. and Dellaglio, F., 1999. Use of PCR-based methods for rapid differentiation of Lactobacillus delbrueckii subsp. bulgaricus and L. delbrueckii subsp. lactis. Applied and Environmental Microbiology 65: 4351-4356.
55. Turroni, F., Foroni, E., Pizzetti, P., Giubellini, V., Ribbera, A., Merusi, P., Cagnasso, P., Bizzarri, B., De'Angelis, G.L., Shanahan, F., Van Sinderen, D. and Ventura, M., 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Applied and Environmental Microbiology 75: 1534-1545.
56. Van Hemert, S., Meijerink, M., Molenaar, D., Bron, P.A., De Vos, P., Kleerebezem, M., Wells, J.M. and Marco, M.L., 2010. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiology 10: 293.
57. Van Hoek, A.H.A.M., Mayrhofer, S., Domig, K.J. and Aarts, H.J.M., 2008. Resistance determinant erm(X) is borne by transposon Tn5432 in Bifidobacterium thermophilum and Bifidobacterium animalis subsp. lactis. International Journal of Antimicrobial Agents 31: 544-548.
58. Waeytens, A., Ferdinande, L., Neirynck, S., Rottiers, P., De Vos, M., Steidler, L. and Cuvelier, C.A., 2008. Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice. Inflammatory Bowel Diseases 14: 471-479.
59. Zoetendal, E.G., Von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A.D.L. and De Vos, W.M., 2002. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Applied and Environmental Microbiology 68: 3401-3407.